Cytosorbents (CTSO) Finished Goods (2023 - 2026)

Cytosorbents' Finished Goods history runs 4 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• Quarterly Finished Goods rose 45.72% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 45.72% YoY) and the FY2025 annual result came in at $3.5 million, up 112.53% from the prior year.
• Finished Goods was $2.7 million for Q1 2026 at Cytosorbents, down from $3.5 million in the prior quarter.
• Across five years, Finished Goods topped out at $3.5 million in Q4 2025 and bottomed at $1.7 million in Q4 2024.
• A 4-year average of $2.3 million and a median of $2.3 million in 2025 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2024 — Finished Goods decreased 10.33% — and 2025, when it soared 112.53%.
• Cytosorbents' Finished Goods stood at $1.9 million in 2023, then declined by 10.33% to $1.7 million in 2024, then jumped by 112.53% to $3.5 million in 2025, then slipped by 23.58% to $2.7 million in 2026.
• Business Quant data shows CTSO's Finished Goods at $2.7 million in Q1 2026, $3.5 million in Q4 2025, and $2.3 million in Q3 2025.